(Q42477181)

1 November 2017

title

Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection (English)

1 reference

1 November 2017

1 reference

Rivier D

1

1 reference

1 November 2017

Bovay P

2

1 reference

1 November 2017

Shah R

3

1 reference

1 November 2017

Didisheim S

4

1 reference

1 November 2017

Mauël J

5

1 reference

1 November 2017

publication date

1 September 1999

1 reference

1 November 2017

1 reference

1 November 2017

volume

21

1 reference

1 November 2017

issue

9

1 reference

1 November 2017

page(s)

461-473

1 reference

Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Leishmania and Trypanosoma surface glycoproteins have a common glycophospholipid membrane anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Immunoprotective Leishmania major synthetic T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Recognition of protozoan parasite antigens by murine T lymphocytes I. Induction of specific T lymphocyte-dependent proliferative response toLeishmania tropica

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Intracellular parasite killing induced by electron carriers. I. Effect of electron carriers on intracellular Leishmania spp. in macrophages from different genetic backgrounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Vaccination of the Leishmania major susceptible BALB/c mouse. I. The precise selection of peptide determinant influences CD4+ T cell subset expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

"Panning" for lymphocytes: a method for cell selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

Cytokines and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00244.X

10.1046/J.1365-3024.1999.00244.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference